Rallybio Corp (RLYB) Stock Analysis

Rallybio Corp (RLYB) is a publicly traded company in the HEALTHCARE sector. It trades at $16.23, carries a market capitalization of $76.61M. This page summarizes the public market data, fundamentals, and frequently asked questions for RLYB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.23
• Market Cap: $76.61M
• EPS: $-1.36
• 52-Week High: $17.57
• 52-Week Low: $2.16

Market Sentiment

Rallybio Corp currently has a Bearish sentiment score of -0.20.

About Rallybio Corp

None

GNG Research Analysis

GNG Research scores Rallybio Corp (RLYB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RLYB.

Frequently Asked Questions

Does RLYB pay dividends?

Rallybio Corp (RLYB) does not currently pay a regular dividend.

What is RLYB's market cap?

Rallybio Corp (RLYB) has a market capitalization of $76.61M with a current stock price of $16.23.